Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.

Bruna R, Benedetti F, Boccomini C, Patti C, Barbui AM, Pulsoni A, Musso M, Liberati AM, Gini G, Castellino C, Rossini F, Ciceri F, Rota-Scalabrini D, Stelitano C, Di Raimondo F, Tucci A, Devizzi L, Zoli V, Zallio F, Narni F, Dondi A, Parvis G, Semenzato G, Lanza F, Perrone T, Angrilli F, Billio A, Gueli A, Mantoan B, Rambaldi A, Gianni AM, Corradini P, Passera R, Ladetto M, Tarella C.

Haematologica. 2019 Nov;104(11):2241-2248. doi: 10.3324/haematol.2018.209932. Epub 2019 Apr 11.

2.

Low-dose radiotherapy for extranodal marginal zone B lymphoma of the lip: Case report and literature review.

Bianco L, Solla SD, Parvis G, Gino E, Bollito E, Filippi AR, Massa F, Ruo Redda MG.

Hematol Oncol Stem Cell Ther. 2018 Dec 31. pii: S1658-3876(18)30121-3. doi: 10.1016/j.hemonc.2018.12.002. [Epub ahead of print]

3.

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial.

Gallamini A, Tarella C, Viviani S, Rossi A, Patti C, Mulé A, Picardi M, Romano A, Cantonetti M, La Nasa G, Trentin L, Bolis S, Rapezzi D, Battistini R, Gottardi D, Gavarotti P, Corradini P, Cimminiello M, Schiavotto C, Parvis G, Zanotti R, Gini G, Ferreri AJM, Viero P, Miglino M, Billio A, Avigdor A, Biggi A, Fallanca F, Ficola U, Gregianin M, Chiaravalloti A, Prosperini G, Bergesio F, Chauvie S, Pavoni C, Gianni AM, Rambaldi A.

J Clin Oncol. 2018 Feb 10;36(5):454-462. doi: 10.1200/JCO.2017.75.2543. Epub 2018 Jan 23.

PMID:
29360414
4.

Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones.

Carrà G, Panuzzo C, Torti D, Parvis G, Crivellaro S, Familiari U, Volante M, Morena D, Lingua MF, Brancaccio M, Guerrasio A, Pandolfi PP, Saglio G, Taulli R, Morotti A.

Oncotarget. 2017 May 30;8(22):35508-35522. doi: 10.18632/oncotarget.16348.

5.

Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation.

Levis M, Piva C, Filippi AR, Botto B, Gavarotti P, Pregno P, Nicolosi M, Freilone R, Parvis G, Gottardi D, Vitolo U, Ricardi U.

Clin Lymphoma Myeloma Leuk. 2017 Jan;17(1):14-22. doi: 10.1016/j.clml.2016.09.008. Epub 2016 Sep 17.

PMID:
27727134
6.

Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.

Ruella M, Filippi AR, Bruna R, Di Russo A, Magni M, Caracciolo D, Passera R, Matteucci P, Di Nicola M, Corradini P, Parvis G, Gini G, Olivieri A, Ladetto M, Ricardi U, Tarella C, Devizzi L.

Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):783-91. doi: 10.1016/j.ijrobp.2015.12.019. Epub 2015 Dec 17.

PMID:
26972651
7.

Diffusion-weighted quantitative MRI to diagnose benign conditions from malignancies of the anterior mediastinum: Improvement of diagnostic accuracy by comparing perfusion-free to perfusion-sensitive measurements of the apparent diffusion coefficient.

Priola AM, Priola SM, Gned D, Piacibello E, Sardo D, Parvis G, Torti D, Ardissone F, Veltri A.

J Magn Reson Imaging. 2016 Sep;44(3):758-69. doi: 10.1002/jmri.25203. Epub 2016 Feb 19.

PMID:
26892919
8.

Usefulness of diffusion-weighted magnetic resonance imaging for assessing early treatment response in lymphoma patients.

Priola AM, Gned D, Parvis G, Torti D, Priola SM.

Acta Radiol. 2015 Feb;56(2):NP10-1. doi: 10.1177/0284185114554254. Epub 2014 Oct 20. No abstract available.

PMID:
25332443
9.

Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis.

Magni M, Di Nicola M, Patti C, Scimè R, Mulè A, Rambaldi A, Intermesoli T, Viero P, Tarella C, Gueli A, Bergui L, Trentin L, Barzan A, Benedetti F, Ambrosetti A, Di Raimondo F, Chiarenza A, Parvis G, Billio A, Attolico I, Olivieri A, Montanari M, Carlo-Stella C, Matteucci P, Devizzi L, Guidetti A, Viviani S, Valagussa P, Gianni AM.

Bone Marrow Transplant. 2014 Apr;49(4):485-91. doi: 10.1038/bmt.2013.214. Epub 2014 Jan 20.

PMID:
24442244
10.

Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italiana Linfomi.

Vitolo U, Ladetto M, Boccomini C, Baldini L, De Angelis F, Tucci A, Botto B, Chiappella A, Chiarenza A, Pinto A, De Renzo A, Zaja F, Castellino C, Bari A, Alvarez De Celis I, Evangelista A, Parvis G, Gamba E, Lobetti-Bodoni C, Ciccone G, Rossi G.

J Clin Oncol. 2013 Sep 20;31(27):3351-9. doi: 10.1200/JCO.2012.44.8290. Epub 2013 Aug 19.

PMID:
23960180
11.

Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy.

Filippi AR, Botticella A, Bellò M, Botto B, Castiglione A, Gavarotti P, Gottardi D, Parvis G, Bisi G, Levis A, Vitolo U, Ricardi U.

Leuk Lymphoma. 2013 Jun;54(6):1183-7. doi: 10.3109/10428194.2012.735667. Epub 2012 Nov 1.

PMID:
23035692
12.

Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma.

Tarella C, Passera R, Magni M, Benedetti F, Rossi A, Gueli A, Patti C, Parvis G, Ciceri F, Gallamini A, Cortelazzo S, Zoli V, Corradini P, Carobbio A, Mulé A, Bosa M, Barbui A, Di Nicola M, Sorio M, Caracciolo D, Gianni AM, Rambaldi A.

J Clin Oncol. 2011 Mar 1;29(7):814-24. doi: 10.1200/JCO.2010.28.9777. Epub 2010 Dec 28.

PMID:
21189387
13.

High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen.

Magni M, Di Nicola M, Carlo-Stella C, Matteucci P, Devizzi L, Tarella C, Benedetti F, Martelli M, Patti C, Parvis G, Rambaldi A, Barbui T, Gianni AM.

Bone Marrow Transplant. 2009 Mar;43(6):509-11. doi: 10.1038/bmt.2008.349. Epub 2008 Oct 27. No abstract available.

PMID:
18955979
14.

Thalidomide-induced partial stable remission in a case of refractory progressive B Cell Chronic Lymphoid Leukemia.

Morotti A, Cilloni D, Parvis G, Guerrasio A, Saglio G.

Leuk Res. 2008 Mar;32(3):506-7. Epub 2007 Jun 4. No abstract available.

PMID:
17544506
15.

CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536.

Morotti A, Parvis G, Cilloni D, Familiari U, Pautasso M, Bosa M, Messa F, Arruga F, Defilippi I, Catalano R, Rosso V, Carturan S, Bracco E, Guerrasio A, Saglio G.

Leukemia. 2007 Jun;21(6):1305-6. Epub 2007 Mar 22. No abstract available.

PMID:
17377595
16.

JAK2 V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disorders.

Rossi D, Deambrogi C, Capello D, Cerri M, Lunghi M, Parvis G, Saglio G, Gaidano G, Cilloni D.

Br J Haematol. 2006 Oct;135(2):267-8. Epub 2006 Sep 4. No abstract available.

PMID:
16956348
17.

Follow-up of mediastinal lymphoma: role of ultrasonography.

De Pascale A, Giorcelli R, Garofalo G, Perotto F, Parvis G, Gino M, Fava C.

Radiol Med. 2006 Sep;111(6):759-72. Epub 2006 Aug 11. English, Italian.

PMID:
16896564
18.

CT findings in primary pulmonary lymphomas.

Cardinale L, Allasia M, Cataldi A, Ferraris F, Parvis G, Fava C.

Radiol Med. 2005 Nov-Dec;110(5-6):554-60. English, Italian.

PMID:
16437041
19.

High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial.

Vitolo U, Liberati AM, Cabras MG, Federico M, Angelucci E, Baldini L, Boccomini C, Brugiatelli M, Calvi R, Ciccone G, Genua A, Deliliers GL, Levis A, Parvis G, Pavone E, Salvi F, Sborgia M, Gallo E; Intergruppo Italiano Linfomi.

Haematologica. 2005 Jun;90(6):793-801.

20.

Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen).

Gianni AM, Magni M, Martelli M, Di Nicola M, Carlo-Stella C, Pilotti S, Rambaldi A, Cortelazzo S, Patti C, Parvis G, Benedetti F, Capria S, Corradini P, Tarella C, Barbui T.

Blood. 2003 Jul 15;102(2):749-55. Epub 2003 Mar 27.

PMID:
12663455
21.

Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma.

Vitolo U, Botto B, Capello D, Vivenza D, Zagonel V, Gloghini A, Novero D, Parvis G, Calvi R, Ariatti C, Milan I, Bertini M, Boccomini C, Freilone R, Pregno P, Orsucci L, Palestro G, Saglio G, Carbone A, Gallo E, Gaidano G.

Leukemia. 2002 Feb;16(2):268-75.

22.

Common-variable immunodeficiency-related lymphomas associate with mutations and rearrangements of BCL-6: pathogenetic and histogenetic implications.

Ariatti C, Vivenza D, Capello D, Migliazza A, Parvis G, Fassone L, Buonaiuto D, Savinelli F, Rossi D, Saglio G, Gaidano G.

Hum Pathol. 2000 Jul;31(7):871-3.

PMID:
10923927
23.

Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients.

Vitolo U, Gaidano G, Botto B, Volpe G, Audisio E, Bertini M, Calvi R, Freilone R, Novero D, Orsucci L, Pastore C, Capello D, Parvis G, Sacco C, Zagonel V, Carbone A, Mazza U, Palestro G, Saglio G, Resegotti L.

Ann Oncol. 1998 Jan;9(1):55-61.

PMID:
9541684
24.

Molecular events in chronic myeloid leukemia progression.

Guerrasio A, Serra A, Gottardi E, Cilloni D, Vischia F, Parvis G, Cilli V, Saglio G.

Leukemia. 1997 Apr;11 Suppl 3:519-21.

PMID:
9209443
25.

Analysis of microsatellite instability in chronic lymphoproliferative disorders.

Volpe G, Gamberi B, Pastore C, Roetto A, Pautasso M, Parvis G, Camaschella C, Mazza U, Saglio G, Gaidano G.

Ann Hematol. 1996 Feb;72(2):67-71.

26.

Distribution of TP53 mutations among acute leukemias with MLL rearrangements.

Lanza C, Gaidano G, Cimino G, Pastore C, Nomdedeu J, Volpe G, Vivenza C, Parvis G, Mazza U, Basso G, Madon E, Lo Coco F, Saglio G.

Genes Chromosomes Cancer. 1996 Jan;15(1):48-53.

PMID:
8824725
27.

Genetic analysis of chromosome 13 deletions in BCR/ABL negative chronic myeloproliferative disorders.

Pastore C, Nomdedeu J, Volpe G, Guerrasio A, Cambrin GR, Parvis G, Pautasso M, Daglio C, Mazza U, Saglio G, et al.

Genes Chromosomes Cancer. 1995 Oct;14(2):106-11.

PMID:
8527391
28.

p53 gene inactivation in acute lymphoblastic leukemia of B cell lineage associates with chromosomal breakpoints at 11q23 and 8q24.

Lanza C, Gaidano G, Cimino G, Lo Coco F, Basso G, Sainati L, Pastore C, Nomdedeu J, Volpe G, Parvis G, et al.

Leukemia. 1995 Jun;9(6):955-9.

PMID:
7596184
29.

Bone marrow microenvironment and the progression of multiple myeloma.

Caligaris-Cappio F, Gregoretti MG, Merico F, Gottardi D, Ghia P, Parvis G, Bergui L.

Leuk Lymphoma. 1992 Sep;8(1-2):15-22. Review.

PMID:
1493467
30.

BCL-2 in B-chronic lymphocytic leukemia.

Caligaris-Cappio F, Ghia P, Gottardi D, Parvis G, Gregoretti MG, Nilsson K, Schena M.

Curr Top Microbiol Immunol. 1992;182:279-86. No abstract available.

PMID:
1283367

Supplemental Content

Loading ...
Support Center